n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Reperfusion Injury in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gazoni, LM; Kron, IL; Laubach, VE; Linden, J; Unger, EB; Walters, DM | 1 |
| D'Agati, VD; Emala, CW; Jacobson, MA; Lee, HT; Ota-Setlik, A; Xu, H | 1 |
| Bril, A; Broadley, KJ; Gardner, NM; Khandoudi, N; Maddock, HL | 1 |
| Galun, E; Matot, I; Rivo, J; Zeira, E | 2 |
| Kukreja, RC; Zhao, TC | 1 |
6 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Reperfusion Injury
| Article | Year |
|---|---|
Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Blood Pressure; Disease Models, Animal; In Vitro Techniques; Lung; Lung Compliance; Lung Diseases; Perfusion; Peroxidase; Piperidines; Protective Agents; Pulmonary Artery; Pulmonary Edema; Rabbits; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A3; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2010 |
A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Genotype; Histamine; Ischemia; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Myoglobinuria; p-Methoxy-N-methylphenethylamine; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Reference Values; Renal Circulation; Reperfusion Injury | 2003 |
Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Coronary Circulation; Endothelium, Vascular; Guinea Pigs; Heart Atria; Hypoxia; Male; Myocardial Ischemia; Myocardial Stunning; Oxygen; Papillary Muscles; Perfusion; Receptor, Adenosine A3; Reperfusion Injury; Time Factors; Xanthines | 2003 |
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |
Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis.
Topics: Adenosine; Animals; Apoptosis; Cats; Disease Models, Animal; In Situ Nick-End Labeling; Lung; Lung Injury; Receptor, Adenosine A3; Reperfusion Injury | 2004 |
Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.
Topics: Adenosine; Animals; Electrophoretic Mobility Shift Assay; Heart; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Inbred ICR; Mitochondria, Heart; Myocardium; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Channels; Receptor, Adenosine A3; Receptors, Purinergic P1; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2002 |